AstraZeneca PLC - Operating Income

AstraZeneca PLC's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Operating-Income" stands at 12.75 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the highest value since 03/31/2012.

AstraZeneca PLC's third quarter result of 3.58 Billion USD for the item "Operating Income" represents an increase of 2.19 percent compared to it's second quarter result.

Also, AstraZeneca PLC's third quarter result of 3.58 Billion USD for the item "Operating Income" represents an increase of 24.93 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), AstraZeneca PLC's third quarter result of 12.75 Billion USD for the item "Operating Income" represents an increase of 5.94 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 24.54 percent compared to the value the year prior.
The 1 year change in percent is 24.54.
The 3 year change in percent is 311.09.
The 5 year change in percent is 224.40.
The 10 year change in percent is 376.31.

The Serie's long term average value is 5.34 Billion United States Dollars. It's latest available value, on 09/30/2025, is 138.68 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 06/30/2022, to it's latest available value, on 09/30/2025, is +615.85%.
The Serie's change in percent from it's maximum value, on 12/31/2011, to it's latest available value, on 09/30/2025, is -0.345%.